Brain Microprocessors in Action

English

Illustration: Peeking into the brain

Brain researchers aim to map nerve cell clusters in action, "conversing" with their peers, processing sensory information, or performing cognitive functions. Each cluster, containing thousands of nerve cells performing a given task, is called a cortical column. The ability to obtain an exact mapping of these columns, which serve as the brain's "microprocessors," is critical to understanding sensory perception and higher cognitive functions. Yet until recently, explorations of the human brain have had to rely on indirect methods with limited accuracy, such as positron emission tomography (PET) and functional magnetic resonance imaging (f-MRI). While these techniques can be used to map an active area at an accuracy of 2-7 mm, mapping brain microprocessors requires an accuracy of 0.5 mm.

 

In the past 15 years, Prof. Amiram Grinvald of the Weizmann Institute's Neurobiology Department has developed optical imaging - a brain-mapping approach that tracks color changes in the blood ferrying oxygen to active microprocessors. Using this technology, Grinvald was able to identify the exact time and place in which nerve cells consume oxygen from the microcirculation system. The high resolution permitted detailed mapping of individual cortical columns.

 

Optical imaging laid the foundation for developing functional MRI by Seiji Ogawa and colleagues at AT&T. Initially scientists had hoped that using f-MRI would enable brain mapping with the same accuracy as that obtained by optical imaging. Indeed, both methods detect a considerable "delayed activity peak" that appears roughly six seconds after the onset of electrical activity. Yet the f-MRI systems could not detect the initial dip," a negative signal that appears earlier, which is clearly visible with optical imaging.


This is where things stood until recently, when Grinvald and colleagues published a paper in Science, suggesting how to enhance f-MRI resolution. Now, a team of researchers from Minnesota University has adopted this recipe and found the missing initial dip using high strength magnetic field f-MRI. The marked improvement in f-MRI should assist attempts to probe human cognition and perception. "f-MRI is far more suitable for non-invasive human brain research and clinical applications than optical imaging or PET," says Grinvald. "It may be used to explore the same brain for many years, enabling researchers to track and map memory traces, aging processes, or functional recovery from trauma or stroke."


And the Minnesota team has already collected the first rewards - the first exact mapping of orientation columns, microprocessors responsible for shape perception in the visual cortex.


Prof. Amiram Grinvald holds the Helen and Norman Asher Professorial Chair in Brain Research. His research is supported by the Horace W.Goldsmith Foundation, New York, Murray Meyer Brodetsky Center of Higher Brain Functions, Mrs. Margaret M. Enoch of New York, the Simon and Marie Jaglom Foundation, New York, and the Carl and Michaela Einhorn-Dominic Brain Research Institute, France.

Illustration: Peeking into the brain
Life Sciences
English

Filters of the Mind

English

Prof. Henry Markram. Complex neuron networks

 

Despite more than a century of research on inhibitory neurons, very little is known about how this small population (10-20% of brain neurons) exerts its controlling effect on the brain.


Inhibitory neurons are pivotal for normal brain development, learning, and memory, so it is not surprising that they are involved in most neurological disorders. A recent Weizmann study, published in the January 2000 issue of Science, reveals key principles underlying the design and function of this inhibitory system.


By repressing the level of activity in neighboring neurons, inhibitory neurons (I-neurons) prevent the brain from quickly spinning out of control into hyperexcited states or full-blown epilepsy. One of the signs in children with autism and attention deficit hyperactivity disorder (ADHD) is I-neuron malfunction: their inhibitory system does not effectively suppress unwanted information, impeding their ability to make choices. I-neuron malfunction is involved in the majority of neurological disorders: Alzheimer's disease, neural trauma, addictions, and a wide range of psychiatric problems such as depression, obsessive-compulsive behavior, and schizophrenia.


In the past, researchers basically thought that I-neurons just spray an inhibitory neurotransmitter called GABA onto their neighbors. But this did not explain how they inhibit the right neurons at exactly the right time and to the right degree. The new study carried out in the laboratory of Prof. Henry Markram of the Neurobiology Department shows how this is achieved.


The research team found new types of I-neurons, revealing that this tiny population is much more diverse than previously thought. Further, using new methods that they developed, the researchers succeeded in recording directly how individual inhibitory neurons control their neighbors. They found that I-neurons build complex synapses (connections) onto their target neurons. The synapses selectively filter inhibitory messages, enabling I-neurons to shut down the activity in neighbors as required. These synapses act as fast-switching "if-then" filtering gates that allow inhibition to be applied only at the exact millisecond and only to the extent necessary.


Each I-neuron fixes complex if-then gates on thousands of neighboring neurons and is therefore "in charge" of controlling their activity. The gates allow I-neurons to rapidly switch their focus onto any neuron to which they are connected. This ingenious design principle is what enables the small group of I-neurons to exert such a sophisticated effect, simultaneously giving personal attention to the activity of each of the neurons to which they are linked.


The researchers showed that a "discussion" between I-neurons and target neurons is involved in deciding which type of if-then gate should be set up to filter the inhibitory message. This decision-making process could allow each neuron in the brain to be inhibited in a unique way. Dubbed the "interaction principle," this process generates maximal diversity of if-then gates, allowing more complex and more refined control over large numbers of neurons.


The researchers went on to reveal a remarkable ability of I-neurons: they can sense neurons that share the same functions in the brain. I-neurons "select" groups of target neurons to construct the same type of if-then gates, possibly enabling the I-neurons to control groups of neurons collectively. It also means that I-neurons can "sniff out" brain neurons that collaborate in the most elementary functions even if they seem different in almost every other way (i.e., they can identify neurons descended from the same "ancestors").


"I-neurons can trace the family trees of neurons. In other words, they could help us to work out how neurons are related to one another. This could one day enable us to map the functional aspect of the brain according to the genealogy of its neurons  an organizing principle we never dreamed would be possible, says Markram. The researchers believe that the ability to detect functionally related groups in the brain, called "the homogeneity principle," results from common signal molecules released by target cells. I-neurons may use the signal molecules to determine what kind of if-then gates to build. Future research designed to identify the nature of these molecules could yield a potent tool for mapping the functional structure of the brain.


Prof. Markram's research is supported by the Minna James Heineman Stiftung, Germany; the Abramson Family Foundation, North Bethesda, Maryland, and the Nella and Leon Benoziyo Center for Neurosciences.

 
computer image of three neurons and their synapses
 

 
 
3-D computer reconstruction of an inhibitory neuron (white) synaptically interconnected to three pyramidal (excitatory) neurons (blue)
Life Sciences
English

The Ins and Outs of Acetylcholine

English

 

Dr. Ehud Ahissar. Acetylcholine's double role
 
 
 
Acetylcholine plays a double role in learning and memory, says a team of scientists from the Weizmann Institute and France's Centre National de la Recherche Scientifique (CNRS).

Prior studies had demonstrated that adding this neurotransmitter to neuronal junctions during learning affects information reception and storage, but subsequent testing of the cell's ability to retrieve the information produced inconsistent results. The findings ranged from a significant or slight improvement following acetylcholine application, to the lack of any learning enhancement whatsoever.

These varying results have baffled scientists throughout the world. However, a team of researchers headed by Drs. Ehud Ahissar of the Weizmann Institute's Neurobiology Department and Daniel Shulz of the Laboratory of Integrative and Computational Neuroscience at CNRS may have solved the nervy riddle.

The secret, researchers found, is to control the level of acetylcholine at the neuronal junctions during both the "ins" and "outs" of information processing -specifically, during information reception and storage, as well as during its retrieval and implementation. This control results in consistently enhanced neuronal learning and information retrieval.

Recently published in Nature, these findings represent yet another step toward understanding the enigma of learning and memory, as well as probing the causes of cognitive deficits observed in Alzheimer's disease and other neurodegenerative disorders.
 
A boost of acetylcholine at the right time

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dr. Ehud Ahissar's research is supported by the Abramson Family Foundation, North Bethesda, Maryland.
 
 

 

 
 
Dr. Ehud Ahissar
Life Sciences
English

Hyde Turned Jekyll

English

 

Illustration of Spinal cord injury and repair

 

While crucial to warding off disease, immune cells have traditionally been thought to be potentially damaging to the central nervous system (CNS) - the brain and the spinal cord. However, a team of Weizmann Institute scientists has now found that immune cells can be recruited to treat partial spinal cord injuries.


Severing the spinal cord causes complete paralysis of the organs innervated by the central nervous system, from the point of injury downward. In fact, even a partial injury of the spinal cord may cause complete paralysis, due to the "hostile environment" created by damaged fibers causing harm to the undamaged fibers. As a result, even in cases of partial spinal cord injury, the damage continues to spread, intensifying the paralysis. Blocking the spread of damage may therefore save the nerve cells undamaged by the initial trauma - and with them, at least some of the patient's motor activity.


Several years ago, a team of Weizmann researchers led by Prof. Michal Schwartz of the Neurobiology Department found that following neuronal injury, immune cells known as macrophages may be recruited to encourage repair and renewed growth of damaged nerve fibers. Schwartz now hopes to take this research one step further. In a study recently published in The Lancet, she proposes adding additional immune cells, known as T-cells, to the damage-control battalion aimed at blocking the spread of damage.


At first glance, this idea seems to oppose the widespread view of immune cells as potentially damaging to the central nervous system. Indeed, while macrophages normally help to heal damaged tissue, previous research by Schwartz revealed that the mammalian CNS actually suppresses an immune response following injury. This suppression may be the result of an evolutionary trade-off. In contrast to fish and other lower life forms capable of repairing damaged CNS fibers, humans and other mammals can repair only peripheral nerves, while injuries to the brain or spine leave them permanently paralyzed or otherwise handicapped.


To get smart, higher animals may have had to pay a price, Schwartz suggests. Along with the asset of complex brains capable of continuous learning came a disadvantage - loss of the self-healing ability existing in lower vertebrates. "The need to prevent immune cells from "remodeling" the brain may have dictated losing the tissue-repair capacity since the immune cells could disrupt the complex and dynamic neuronal networks that build up during a lifetime," says Schwartz.


T-cells prevent infection by seeking out and destroying pathogenic "enemies" that infiltrate the body. But the body also contains T-cells that are directed against its own components. The accepted notion is that these anti-self T-cells may cause autoimmune diseases, such as multiple sclerosis and diabetes. However, the Institute scientists have shown that a controlled amount of these autoimmune cells, when directed against specific components, can assist in curbing injury-induced neuronal damage.


Following treatment with anti-self T-cells, rats with partial injuries of the spinal cord regained some motor activity in their previously paralyzed legs while untreated rats developed increasing and sometimes even total paralysis. These findings may lead to an innovative clinical treatment for preventing total paralysis after partial spinal cord injury.


Immune cells have a double-edged sword potential in treating neuronal injuries, Schwartz explains. The key to using them effectively is to extract the cells from the patients blood and increase their amount and activity in such a way that their healing effect is maximized while their potential risk is minimized. The cells are then reintroduced into the damaged neuronal area. Schwartz: "The concept is to work together with the body's existing self-repair mechanism, which apparently requires encouragement and monitoring."


Other scientists participating in this study were Weizmann Profs. Irun Cohen of the Immunology Department, Michal Neeman of the Biological Regulation Department, and Prof. Solang Akselrod of Tel Aviv University. Working with Prof. Michal Schwartz were Dr. Eti Yoles, Dr. Eugenia Agranov, Ehud Hauben, Uri Nevo, and Gila Moalem, all of the Neurobiology Department.


Prof. Michal Schwartz holds the Maurice and Ilse Katz Chair of Neuroimmunology. Her research is funded Proneuron Ltd., the Alan T. Brown Foundation to Cure Paralysis, New York, the Glaucoma Research Foundation, San Francisco, California, and the Jerome and Binette Lipper Award.

Illustration: Spinal cord injury and repair
Life Sciences
English

Alzheimer's and the Wheel

English

    

Prof. Irith Ginzburg. Deleting parts of the map
 
 

 

It is generally assumed that human beings invented the wheel, but as Prof. Irith Ginzburg shows in an article published in the Journal of Neuroscience, wheel-borne carriages fitted on tracks and led by coachmen have always existed within us - in our nerve cells. This means of transportation accommodates a molecule called tau mRNA, a critical factor in the formation of "tangles."
 
Tangles are long chains whose main ingredient is a protein called tau. They are a hallmark of certain forms of Parkinson's disease and are one of the two essential defining characteristics of Alzheimer's disease. When tau forms tangles, it is being produced in excess. So knowing the basic mechanisms of tau is vital to understanding these diseases.
 
"Tau protein is essential for nerve cell growth," explains Ginzburg. "In normal cells, it is found primarily in the axon [the long projecting arm of nerve cells that transmits signals to and receives signals from other nerve cells]. However, in patients suffering from Alzheimer's and Parkinson's disease it forms "tangles" and can be found throughout the cell and not only in the axon."
 
Curious to find out why this was so, Ginzburg went to the core - the nerve cell's nucleus, containing all of the cell's genetic information. In 1996, she tracked down the gene responsible for tau production and pinpointed the gene "promoter," which regulates gene expression (the level of gene expression determines the amount of protein that will be produced). She thus zeroed in on the basic mechanism determining the level of tau production.
 
Ginzburg then went on to analyze tau mRNA, the messenger that conveys the "secret combination" for the proteins production to a "protein factory," where tau is built. She found that tau mRNA normally travels only to the axon. The reason: tau mRNA has a built-in map specifying where it's supposed to go. But what impedes tau mRNA's safe arrival at the axon in Alzheimer's and Parkinson's disease patients? This is not yet fully understood. A messenger with a map shouldn't have trouble reaching a fixed destination. Ginzburg suspected that a faulty vehicle might be involved.

She showed that tau mRNA is transported by a "wheel" that rolls from the nucleus to the axon, on microtubules (long "tubes" that are present in all cells). The wheel is composed of various proteins and latches onto tau mRNA's map. One of the proteins forming the wheel acts as a "conductor," guiding the whole complex to its destination.
 
Observing that the proteins bind to tau mRNA's map, Ginzburg decided to delete minute parts of the map until she found which part, when deleted, would prevent the vehicle from reaching the axon.
 
Since different parts of the map correspond to different binding proteins, deleting a specific part of the map in effect causes the deletion of a specific protein from the wheel. This was how Ginzburg found that when the wheel lacks a certain protein - one from the "elav" family of proteins - tau mRNA accumulates in the cell body, "on the road" to the axon. This finding could explain why tangles (which, as noted earlier, form as a result of excess production of tau) are scattered throughout the cell.
 
Another interesting effect of the deletion was noted: when tau mRNA did not reach the axon due to the absence of the elav protein, the development of axons was impaired. This serves as strong evidence that the elav protein and tau play a central role in the branching out of nerve cells critical for nerve cell communication.
 
Ginzburg also settled a hotly debated issue when she showed that some tau mRNA molecules continue to migrate throughout the axon. Until now, some scientists believed that all tau mRNA molecules reaching the protein factories at the beginning of the axon invariably stopped there. "The molecules that continue to migrate within the axon may act as "reserve" molecules," explains Ginzburg. "They station themselves near protein factories throughout the axon and await an additional signal to bring about the creation of the protein. Thus, in case of tau shortage, the cell can immediately produce more of the protein precisely where it is needed."
 
Prof. Irith Ginzburg.
Life Sciences
English

The Healing Connection

English

Overcoming spinal cord injury in mice

1. Nerve signals from the brain go down the spine to the front and hind limbs

2. Damage to the spine interrupts the signals to the hind legs, causing their paralysis

3. Immune system cells (red) try to heal the damage, but they are blocked by a protective mechanism of the central nervous system (green )

4. A segment of the peripheral nerve (purple) is incubated with the immune cells and "activates" them 

5. "Activated" immune cells are returned to the damaged site

6. They manage to overcome the protecitve mechanism an partially heal the damage

7. As a result, the paralysis is partially overcome

 

Weizmann Institute scientists have managed to partially heal the damaged spinal cords of laboratory animals, according to a study reported in the July issue of Nature Medicine. A team led by Prof. Michal Schwartz of the Neurobiology Department used an innovative treatment which allowed rats to regain partial movement in their hind legs that had been paralyzed by damage to the spine.

"The results of our experiments are promising," says Prof. Schwartz. "However, for the moment, they have been achieved only in rats. A lot of additional research still needs to be done before the new treatment is available to humans."

It has long been known that lower animals, such as fish, can repair damaged fibers in the central nervous system ­ the spinal cord and the brain ­ and restore lost function. In contrast, mammals, including humans, can only repair injuries to the peripheral nerves, while injuries to the brain or spine leave them permanently paralyzed or otherwise handicapped.

The new approach is based on Schwartz's theory which states that the loss of this reparability occurred in the course of evolution, and is due to a unique relationship between the central nervous and immune systems. More specifically, Schwartz believes this loss was probably dictated by the need to protect the mammalian brain from the effects of the immune system. While immune cells normally help to heal damaged tissue, their access to the brain would disrupt the complex and dynamic neural networks that build up during an individual's lifetime.

Generally, when tissue damage occurs, immune cells known as macrophages swarm to the injured site where they remove damaged cells and release substances that promote healing. The central nervous system of mammals is different in this regard: When damaged, it is not effectively assisted by the immune system.

Schwartz's team discovered that this is because the mammalian central nervous system has a mechanism that suppresses the macrophages. As a result, macrophages are recruited to central nervous system injuries at a lower rate, and those that are recruited fail to become optimally "activated" and effective.

These findings led to a series of experiments with rats in the course of which the researchers managed to overcome the limited ability of the damaged central nervous system to recruit and activate the macrophages. They isolated macrophages and incubated them in a test tube in the presence of a damaged peripheral nerve. The macrophages, which received the distress signals of the damaged peripheral nerve, became activated.

At this stage, the researchers returned the activated macrophages to the damaged site in the central nervous system of the paralyzed rat. The transplanted macrophages created a growth-inducing environment around the damaged tissue. As a result of the treatment, the rats were able to regain parti al motor activity in their previously paralyzed legs. They were able to move their hind legs and several animals were even able to place their weight upon them.

A major innovative aspect of such treatment lies in promoting the animal's own self-repair mechanism. In fact, the new treatment offers the option of using the animal's own cells for this purpose.

Further research is necessary to see if this approach will work in higher animals, such as humans

Yeda Research & Development Co. Ltd., the Weizmann Institute's technology transfer arm, has submitted patent applications for the new treatment. In order to promote this research and develop it furt her for possible clinical use, Yeda has entered into a licensing agreement with Proneuron Biotechnology Ltd., a start-up company located in the Kiryat Weizmann Industrial Park adjacent to the Institute.

renewing the connection

Life Sciences
English

Science Without Frontiers: Putting the Brain to Work

English

It takes less than a second from the time your eyes register an image until your brain tells you what you are seeing. But what happens during that interval? How does the brain process visual images, and how can it do this so much better than any machine?

Profs. Amiram Grinvald and Ad Aertsen and Dr. Amos Arieli -- all of the Neurobiology Department -- are working with Prof. Shimon Ullman of the Applied Mathematics and Computer Science Department to find the answers by studying how groups of brain cells interact with one another to process visual information. In experiments, the scientists show pictures to subjects and monitor their brain activity by optical imaging, a technique pioneered by Grinvald. They also use theoretical mathematics to develop models of visual object recognition, and to interpret and predict the effects on brain activity of different attributes of the pictures, such as their angle and distance, and whether they are moving or still. The benefits of working together go both ways, according to Grinvald and Ullman.

"The brain is the most successful computing machine known," says Grinvald. "For neurobiologists, mathematics and computer science provide tools that enable us to analyze the results of our experiments and construct theoretical models that offer predictions we can test. For mathematicians who want to create artificial intelligence, the brain is a model that already does almost everything they want to imitate, so they can benefit from understanding how it operates."

Research by Arieli and others in Grinvald's team, reported in Science, has already shown that an image produces different brain activity patterns in the same individual at different times, depending on the viewer's state of mind. Significantly, however, the team has now found that if internal activity is removed, a small "core" portion of brain activity is the same whenever the same image is presented.

Further clarification of these processes is likely to have significant implications for two broad areas: brain research, where it may help explain how the brain accomplishes higher functions, and computers, where scientists hope to create intelligent artificial systems. For example, a computer can scan a picture of a face but when shown that face from a different angle, it does not recognize it. An "intelligent" computer would recognize the face from any angle or in motion, just as the brain does. Brain-like methods that might allow artificial vision systems to recognize objects in a wide range of conditions were described in Ullman's recent book High-Level Vision (MIT Press).

"Our project is a blend of computer science and brain science," says Ullman, "and we believe our work is important for both technology and biology."
Life Sciences
English

From Plato to Grinvald

English

Prof. Amiram Grinvald. Revealing the primary visual cortex

An article reviewing the development of man's understanding of vision, which recently appeared in the Journal of NIH Research, begins with Plato's theory of "visual fire" and ends with elucidation of functional organization in the visual cortex of the brain by Prof. Amiram Grinvald of the Institute's Department of Neurobiology.


According to the article, the first detailed theory of vision was propounded by early Greek philosophers such as Plato, who held that a ray of visual fire emanated from each eye and mixed with light to produce an invisible structure between the eye and an observed object. Galen, a second-century Roman physician, suggested that the brain is essential for consciousness and perception. In 1490, da Vinci reiterated Galen's concept that the eyes communicate directly with the brain. This long line of research, pursued by many scientists, was followed by the seminal work of Cajal and that of Hubel and Wiesel, who won Nobel Prizes for their contribution to brain research. And the most recent advances, according to the Journal, have been made by Prof. Gary Blasdel of the Harvard Medical School and the Weizmann's Prof. Grinvald.


"Independently," the Journal reports, "since 1986 they have used cameras to measure changes in the activity of neurons in exposed surfaces of the visual cortex as animals view lines of different orientations. They mapped the location of many different orientation columns on the surface of the primary visual cortex in a single test animal, at a higher resolution than is possible with standard methods of labeling."


The optical imaging technique that they used, which allows the direct visualization of electrical activity in the living brain, was developed by Grinvald at the Weizmann Institute in 1984. In enables scientists to visualize the intricate functional architecture of the brain, that is, the layout across the cortical surface of brain cells involved in distinct processing tasks. Optical imaging of functional borders is also being applied by neurosurgeons to minimize damage during tumor removal. The technique grew out of the 1968 pioneering work of Tasaki and Cohen showing that electrical activity of single nerve cells can be monitored by light.

Referring specifically to Grinvald's work, the Journal states: "He showed that the orientation columns are arranged in radially symmetric, fan-like structures he called 'pinwheels'. In this arrangement, a set of orientation columns intersects at the center of the pinwheel." This information sheds new light on the functional organization of the nerve cells responsible for the perception of object shapes. This work was done together with Prof. Tobias Bonhoeffer at Rockefeller University.

Thanks largely to these investigations, the NIH Journal concludes, "researchers currently understand the primary visual cortex better than any other part of the brain."
Prof. Grinvald, who holds the Helen and Norman Asher Chair in Brain Research, is the director of the Grodetsky Center for the Research of Higher Brain Functions.
 

Life Sciences
English

Morphine Effect on Key Brain Mechanism Determined

English

 

Prof. Rabi Simantov. Inhibited dopamine uptake
 

The chemistry of morphine addiction is being studied by Prof. Rabi Simantov of the Department of Molecular Genetics and Virology. Part of this research, recently published in Neurosciences Letters, may shed light on the addictive properties of a wide range of other substances, including alcohol, amphetamines, cocaine and nicotine.


The euphoria accompanying addiction to morphine and various other drugs results from excessive activity on the part of dopamine -- a neurotransmitter that relays impulses between nerve cells in the brain. Ordinarily, dopamine signals are turned off when the neurotransmitter is absorbed by a neuron; any inhibition of this process leads to excessive signaling. Prof. Simantov has now shown that chronic exposure to morphine inhibits dopamine uptake via a previously unrecognized mechanism.

In animal studies, morphine addiction was found to reduce the number of nerve-cell transporters that normally absorb dopamine and turn off its signals.

Prof. Simantov also showed that this reduction of transporters takes place only in the anterior basal forebrain -- the region containing drug "reinforcement and reward pathways." Since these pathways are strongly associated with the brain activity responsible for euphoria and analgesia -- phenomena induced by substances as varied as alcohol, amphetamines, cocaine and nicotine -- the addiction mechanism triggered by morphine is likely to be involved in the brain's response to these substances as well. The findings, therefore, might provide a basis for new strategies aimed at reducing dependency on some or all of these habit-forming drugs.
 
The study was supported, in part, by the Anti-Drug Authority of Israel, and the Office of the Chief Scientist in the Israeli Ministry of Health. Prof. Simantov holds the André Lwoff Chair of Neurogenetics.
 
Life Sciences
English

Pages